glp 1 and schizophrenia Glucagon-like peptide-1 receptor agonists risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study An analysis on the role

In 2025, the FDA approved Wegovy HD a higher-dose semaglutide formulation for metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH

crosses the blood-brain barrier*

After logging in to your account, navigate to your Upcoming Visit details, found on the home page

The market in Canada is witnessing significant growth due to the growing emphasis on aging support and energy metabolism, with a large consumer base

Cumulative effect of simvastatin, L-arginine, and tetrahydrobiopterin on cerebral blood flow and cognitive function in Alzheimers disease

By managing this complex documentation, Novanex enhances the ability of 503A pharmacies to focus on what they do best: meeting individual patient needs